Showing results (171-180 of 558) with videos related to
Sort By:
Pageof 56
Neuroscience|January 1, 1990
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic studyF Thibaut, E C Hirsch, R Raisman, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|November 4, 1998
Deficit in evaluating pre-determined sequences of script events in patients with Parkinson's diseaseT Zalla, A Sirigu, B Pillon, et al.Annals of Neurology|May 1, 1993
Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteinsP Vermersch, A Delacourte, F Javoy-Agid, et al.Journal of Neural Transmission. Supplementum|January 1, 1997
Neuronal vulnerability in Parkinson's diseaseE C Hirsch, B Faucheux, P Damier, et al.Journal of Neurochemistry|May 1, 1997
Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?M Ruberg, B Brugg, A Prigent, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical studyN Gouider-Khouja, M Vidailhet, A M Bonnet, et al.Neuroscience|July 1, 1994
Distribution of manganese-dependent superoxide dismutase in the human brainP Zhang, P Anglade, E C Hirsch, et al.European Journal of Pharmacology|March 23, 1984
[3H]spiperone binding in the nigrostriatal system in human brainM Ruberg, B Bokobza, F Javoy-Agid, et al.Neurology|July 1, 1994
Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseasesB Pillon, B Deweer, A Michon, et al.Revue Neurologique|January 1, 1984
[Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience]F Lhermitte, R Marteau, E Roullet, et al.Pageof 56